CRON FY 2022 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$87M+34.4% YoY

Gross Profit

$15M17.8% margin

Operating Income

-$111M-128.4% margin

Net Income

-$169M-194.5% margin

EPS (Diluted)

$-0.45

Cash Flow

Operating Cash Flow

-$89M

Free Cash Flow

-$94M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$72M

Stockholders' Equity

$1.1B

Cash & Equivalents

$765M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$65M	+34.4%
Gross Profit	$15M	-$18M	+187.7%
Operating Income	-$111M	-$292M	+61.8%
Net Income	-$169M	-$396M	+57.4%